Cargando…
Clinical characteristics and targeted therapy of different gene fusions in non-small cell lung cancer: a narrative review
BACKGROUND AND OBJECTIVE: Lung cancer is the most fatal malignant tumor in the world. Since the discovery of driver genes, targeted therapy has been demonstrated to be superior to traditional chemotherapy and has revolutionized the therapeutic landscape of non-small cell lung cancer (NSCLC). The rem...
Autores principales: | Chen, Jiayan, Xu, Chunwei, Lv, Jiawen, Lu, Wanjun, Zhang, Yixue, Wang, Dong, Song, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183389/ https://www.ncbi.nlm.nih.gov/pubmed/37197619 http://dx.doi.org/10.21037/tlcr-22-566 |
Ejemplares similares
-
A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma
por: Hernandez, Susana, et al.
Publicado: (2023) -
Could cell division cycle protein 42 be a target for lung cancer treatment?
por: Lv, Jiawen, et al.
Publicado: (2019) -
Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas
por: Matter, Matthias S., et al.
Publicado: (2020) -
Targeted therapy of RET fusion-positive non-small cell lung cancer
por: Shen, Zixiong, et al.
Publicado: (2022) -
Newly diagnosed non‐small cell lung cancer with interstitial lung abnormality: Prevalence, characteristics, and prognosis
por: Zhu, Min, et al.
Publicado: (2023)